stella
beta
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors — Stella
Recruiting
Back to Solid Tumor trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(5 sites)
United States
Banner MD Anderson Cancer Center (BMDACC), Gilbert, Arizona
Henry Ford Health System, Detroit, Michigan
Carolina BioOncology Institute, Huntersville, North Carolina
Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma
MD Anderson Cancer Center, Houston, Texas
View full record on ClinicalTrials.gov